ATAllisson Briggitte Vite Tolozano

Allisson Briggitte Vite Tolozano

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Allisson Briggitte Vite Tolozano has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Gynecologic Health Across the Lifespan: Systemic Pathways and Long-Term Clinical Outcomes

    by Abril Samantha Hernández Silva, Elizabeth Contreras Vargas, Diego Xavier Aráuz Paredes, Henry Alexander García Hernández, Adrián Jesús Santoyo Rojas, Angelica Lucía Jiménez López, Allisson Briggitte Vite Tolozano, Yuly Andrea Márquez Castañeda

    Gynecologic health has traditionally been approached through a reproductive-centered lens; however, growing international evidence demonstrates that gynecologic conditions, hormonal transitions, and interventions exert significant systemic and long-term clinical effects across the female lifespan. This narrative review synthesizes high-impact literature addressing gynecologic health beyond reproductive function, with particular emphasis on metabolic, cardiovascular, endocrine, immune-inflammatory, genitourinary, and oncologic outcomes. Chronic conditions such as polycystic ovary syndrome and endometriosis are examined as early and midlife determinants of long-term systemic risk, while menopause is analyzed as a critical biological transition influencing cardiometabolic health. The review also explores the long-term implications of gynecologic surgery, hormonal contraception, and menopausal hormone therapy, highlighting the complexity and context-dependence of associated risks and benefits. By adopting a life-course and systems-based perspective, this article underscores the importance of integrating gynecologic history into comprehensive risk assessment, preventive strategies, and medical education. The findings support a reframing of gynecology as a foundational component of women’s overall health, with relevance across diverse healthcare settings, including Mexico, Colombia, and Ecuador.

  • Early Detection Pathways and Integrated Therapeutic Models for Postpartum Depression: A Global–Latin American Perspective

    by Abril Samantha Hernández Silva, María Alejandra Cogollo Tarazona, Nicolás López Castellanos, Allisson Briggitte Vite Tolozano, Miguel Horacio Quijano, Mirka Lisbeth Alchundia Solís, María Fernanada Velásquez Barba, Dulce Eliani Gutiérrez Santillán

    Postpartum depression (PPD) is a major global health concern that affects a substantial proportion of women during the first year after childbirth. Despite advances in screening and intervention, important gaps persist in early detection and access to integrative care—particularly in middle-income regions such as Mexico, Colombia, and Ecuador. This review synthesizes recent international evidence to examine the effectiveness of early identification strategies and therapeutic interventions designed to improve maternal mental-health outcomes. Findings show that PPD prevalence remains consistently high worldwide, but rates are significantly elevated in Latin America, reflecting contextual stressors, socioeconomic disparities, and limited availability of specialized perinatal mental-health services. Screening tools such as the Edinburgh Postnatal Depression Scale (EPDS) and PHQ-9 continue to demonstrate robust psychometric performance, yet emerging models—especially repeated web-based assessments and digital phenotyping—offer enhanced sensitivity for identifying women at risk. Therapeutically, multidisciplinary collaborative care models consistently achieve the strongest clinical outcomes, followed by cognitive behavioral therapy (CBT) and blended in-person/digital approaches. Digital interventions, while highly scalable, show variable adherence depending on the level of clinician guidance. Analysis of risk factors underscores that psychosocial determinants—including prior depression or anxiety, low social support, economic stress, and sleep disturbance—are more influential in predicting PPD than obstetric complications alone. Overall, the review emphasizes the importance of comprehensive, culturally responsive, and system-integrated strategies that combine validated screening tools, psychological therapies, digital resources, and social-support interventions. Strengthening PPD care in Latin America will require expanding screening programs, improving continuity between obstetric and mental-health services, and investing in community-based and technological supports. These measures are essential to improve maternal well-being and long-term family health.

  • Precision Gynecology Through Microbiome Science: Clinical Patterns, Biomarkers, and Global Perspectives

    by Abril Samantha Hernández Silva, Allisson Briggitte Vite Tolozano, Elsa Noralma Lucas Parrales, Guillermo Moises Díaz Quiroz, María Fernanda González Torres, Ángela Patricia López Alvarado, Augusto Cam Rojas, Vanessa Ma Lei

    The vaginal microbiome has emerged as a critical determinant of gynecologic health, influencing infectious, reproductive, endocrine, and oncologic outcomes through complex ecological and host–microbial interactions. This review synthesized evidence from 20 recent studies to characterize the relationships between microbial community structures and major gynecologic disorders, incorporating perspectives from North America, Europe, Asia, Africa, and Latin America, including Mexico, Colombia, and Ecuador. Across the literature, Lactobacillus-dominant communities consistently appeared as protective biological states, whereas anaerobic-rich dysbiosis and unstable community state types (CSTs) were strongly associated with bacterial vaginosis, pelvic inflammatory disease, infertility, implantation failure, preterm birth, HPV persistence, and chronic inflammatory conditions. Temporal analysis revealed a substantial rise in microbiome-focused publications between 2020 and 2022, while geographic mapping exposed persistent disparities, with limited representation from Latin American populations. These findings underscore the need for region-specific research to refine diagnostic frameworks and develop clinically relevant, culturally appropriate interventions. The review highlights emerging translational opportunities, including microbiome-guided diagnostics, personalized risk stratification, and targeted therapeutic strategies aimed at restoring microbial stability. Overall, the vaginal microbiome represents a promising frontier in precision gynecology with the potential to transform prevention, diagnosis, and management of complex gynecologic disorders worldwide.